Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant
Clinical trial NCT00565474 · COMPLETED
Trial details
- NCT number
- NCT00565474
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2007-10-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.